Moonlake Immunotherapeutics · NASDAQ:MLTX
Santos da Silva Jorge sold 150,000 Moonlake Immunotherapeutics shares (Form 4)
Traded Apr 10 to Apr 13, 2026 · Filed Apr 14, 2026
From Apr 10 to Apr 13, 2026, Santos da Silva Jorge (Director, Chief Executive Officer) sold 150,000 Moonlake Immunotherapeutics shares at an average US$18.35 for US$2.75M, leaving 2,924,893 shares. Filed Apr 14, 2026 (Form 4).
- Sold
- 150,000 shares
- Price
- US$18.35 average (US$18.23 to US$18.41)
- Value
- US$2.75M
- Holding after
- 2,924,893 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 10, 2026 | Class A ordinary shares, par value $0.0001 per share | Sale | 98,127 | US$18.41 | 2,976,766 | Direct |
| Apr 13, 2026 | Class A ordinary shares, par value $0.0001 per share | Sale | 51,873 | US$18.23 | 2,924,893 | Direct |
Source
Related
- Moonlake Immunotherapeutics
- Santos da Silva Jorge
- Moonlake Immunotherapeutics shareholders
- Form 4 · Santos da Silva Jorge · Jul 13, 2026
- Form 4 · Santos da Silva Jorge · Jul 2, 2026
- Form 4 · Reich Kristian · Jul 29, 2026
- Form 4 · Reich Kristian · Jul 23, 2026
- Form 4 · Reich Kristian · Jul 21, 2026
- Form 4 · Reich Kristian · Jul 20, 2026
- Form 4 · Bodenstedt Matthias · Jun 23, 2026